Episode 149: Health Disparities and Barriers in Metastatic Castration-Sensitive Prostate Cancer

ONS member Randy Jones, PhD, RN, FAAN, professor at the University of Virginia School of Nursing in Charlottesville and member of the Blue Ridge of Virginia ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss racial and other health disparities in patients with metastatic castration-sensitive prostate cancer. Astellas and Pfizer Inc. provided support for this podcast episode through an educational grant. Music Credit: "Fireflies and Stardust" by Kevin MacLeod   Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 2, 2023. The planners and faculty for this episode have no conflicts to disclose, and the episode has no commercial support. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.  Episode Notes  Check out these resources from today's episode:   The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. ONS Voice article: Prostate Cancer Clinical Trials Don't Reflect Racial Diversity—And It's Getting Worse Over Time  ONS Voice article: U.S. Sees Another Record-Breaking Decrease in Cancer Deaths, but Disparities Remain  Oncology Nursing Forum article: Hidden Patients, Hidden Partners: Prostate Cancer Care for Gay and Bisexual Men  Jones discusses the decision-making tool he developed for patients with prostate cancer.  American Cancer Society information on prostate cancer  Centers for Disease Control and Prevention information on the Tuskegee study  National Cancer Institute information on prostate cancer for providers  National Comprehensive Cancer Network clinical practice guidelines on prostate cancer  Prostate Cancer Foundation  Zero Prostate Cancer Summit